pharmaphorum
APRIL 6, 2021
From #MeToo to Black Lives Matter, as a society we have been discussing the relationship between representation and equality more than ever over the last few years. . But while progress is being made in so many areas, people with disabilities are still struggling to find a voice above the accepted narrative, says Ross Lannon, the 27-year-old blogger and multi-media content creator behind A Life on Wheels.
Outsourcing Pharma
APRIL 8, 2021
The collaboration will enable Charles River clients to access Valenceâs artificial intelligence platform in their pharmaceutical development projects.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Druggist
APRIL 6, 2021
Lacri-lube has been out of stock for months. Still, after all this time, some patients get repeat prescriptions issued with Laci-Lube on it. Patients who have Lacri-Lube eye ointment on their ‘repeats’ should contact their surgery and ask to remove it and replace it with Lacri-lube alternative eye ointments. I will list in this post the best Lacri-Lube alternative eye ointments and gels.
Pharma Times
APRIL 9, 2021
The drug was discovered through an AI-design platform within just eight months of project initiation
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
pharmaphorum
APRIL 8, 2021
A digital tool used to treat attention-deficit hyperactivity disorder (ADHD) is being tested to see if it can help counter lingering, fuzzy thinking in COVID-19 survivors, a condition sometimes known as ‘brain fog’ An app called EndeavorRx – developed by PureTech Health-backed Akili Interactive – will be tested in two clinical trials to see if it can improve cognitive function in people who have recovered from COVID-19 but still show cognitive problems weeks or months later.
Outsourcing Pharma
APRIL 5, 2021
The April 6 webinar, Clinical Development Innovations, will touch upon artificial intelligence, machine learning, ethics and other impactful issues.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Pharma Times
APRIL 8, 2021
Kesimpta is the first self-administered B-cell therapy for patients with relapsing forms of multiple sclerosis
pharmaphorum
APRIL 8, 2021
Gilead’s $21 billion purchase of Immunomedics and its potential blockbuster Trodelvy continues to pay off, as the drug has now been approved by the FDA for triple-negative breast cancer. . Trodelvy (sacituzumab govitecan) was granted accelerated approval by the FDA in April last year, and is now indicated for adults with triple-negative breast cancer who have received at least two previous therapies for metastatic disease.
Outsourcing Pharma
APRIL 7, 2021
A leader from the global CRO discusses how putting the patient first in clinical research is essential to discovering new therapies for orphan diseases.
Pharma Marketing Network
APRIL 9, 2021
This content is password protected. To view it please enter your password below: Password: The post Protected: Digital TV: A Boon for Pharma Marketers appeared first on Pharma Marketing Network.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Pharma Times
APRIL 6, 2021
NHS England is rolling out Roche's new combined treatment Phesgo, which drastically cuts administration time
pharmaphorum
APRIL 9, 2021
The FDA says it has uncovered “deficiencies” in the marketing application for Provention Bio’s much-anticipated drug teplizumab for the prevention of type 1 diabetes (T1D) that could delay its review. The issues are holding up discussions between the agency and company about labeling and post-marketing requirements for teplizumab, and are concentrated around the pharmacokinetics data for the antibody, and whether it is comparable to the drug that its original developer Eli Lill
Outsourcing Pharma
APRIL 8, 2021
The AWARE for All virtual event series aims to educate and engage the public as important partners in clinical trials and development of new treatments.
Pharma Mirror
APRIL 9, 2021
Isolation gowns are essential equipment for infection-control strategies. They are the second most used PPE items after gloves. They were originally designed for health workers but can also be worn by random people to protect them from infections when they come in contact with infected people or substances. The different types of isolation gowns There are two major types of isolation gowns made for healthcare purposes: Surgical gowns: A surgical gown is a personal protective garment that is used
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Birth Control Pharmacist
APRIL 8, 2021
Free 22-page report describing the current landscape of direct pharmacy access to contraception in pharmacies, state policy approaches and experiences, as well as implementation. The 2020 report includes information for policy efforts in 2020, along with emphasis on definitions of reimbursement vs. payment and a new appendix with model bill elements. .
pharmaphorum
APRIL 7, 2021
Genmab’s CEO Jan van de Winkel has said he would consider spinning out a smaller autoimmune diseases biotech, while ruling out any interest in a merger with big pharma. . In an interview with pharmaphorum, van de Winkel noted that the company’s drugs could be used for diseases outside of cancer, where Copenhagen-based Genmab first made its mark. A drug it originally developed to treat leukaemia has been repurposed by Novartis as a treatment for multiple sclerosis.
Outsourcing Pharma
APRIL 7, 2021
Especially with the COVID-19 pandemic impacting studies, the company says, putting patients at the center of studies and trial tech must be top priority.
Lifewell Rx Pharmacy
APRIL 7, 2021
Most of us go to the pharmacy to get our prescriptions, an occasional treat, or a toiletry item. But did you know that they can do so much more for you? As the community’s leading independent pharmacy in Louisville, Kentucky , at LIFEWELL RX PHARMACY here are some of the services from your pharmacy that you may be missing out on: Pharmacy consultations.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Colors Make me Happy
APRIL 6, 2021
The COVID19 pandemic has amplified work-life challenges for many work-from-home employees as boundaries between work and home life become blurred. In these difficult times, the reality is that we need to make a living, but also need to make sure that we are still “living” to avoid becoming burned out. To address these new challenges, many companies have focused on employee well-being and have associated a work-life imbalance with excessive work demands.
pharmaphorum
APRIL 9, 2021
UK artificial intelligence specialist Healx has begun a partnership with two medical charities that aims to uncover new therapies for the neurodegenerative disease Friedreich’s ataxia (FA). . Healx has joined forces with Ataxia UK and the US-based Friedreich’s Ataxia Research Alliance (FARA) on the project, and will use its AI-powered drug discovery platform Healnet to try to find already used drugs that could be repurposed as treatments for FA.
Outsourcing Pharma
APRIL 7, 2021
A father of two boys with Duchenne muscular dystrophy is running the Austin Marathon to raise funds toward pursuit of a cure for the rare, fatal disease.
Mission-Driven Marketing Blog
APRIL 5, 2021
Inbound Marketing, a methodology which seeks to attract leads through generating valuable content and experiences, has been outpacing traditional forms of marketing, like Outbound Marketing or ‘Push’ Marketing, in recent years. Inbound Marketing solves the problem of contacts being overwhelmed and oversaturated with marketing and sales messaging and builds longer-lasting, mutually-beneficial relationships.
Pharma Times
APRIL 9, 2021
The combination is not considered to be a cost-effective use of NHS resources in this setting
pharmaphorum
APRIL 8, 2021
UK biotech Achilles Therapeutics has completed its initial public offering (IPO) in the US, raising $175.5 million that will be used to take its personalised T cell therapy for lung and skin cancers through proof-of-concept trials. The new funding will also be used to advance two more T cell programmes for head and neck and kidney cancers into human testing, develop and expand its bioinformatics and manufacturing capabilities, and increase its use of automation, according to an SEC filing.
Outsourcing Pharma
APRIL 5, 2021
The clinical research tech specialists, which had held 60% of Q2 Diagnostics, will now wholly own the comprehensive clinical laboratory services company.
Med Ed 101
APRIL 7, 2021
We blogged about doxepin a few weeks ago now and I had a colleague bring this article to my attention. The relationship between doxepin and CYP2D6 is a very important one and I wanted to discuss it further with some potential drug interactions that may come up in practice. Here’s the abstract from the article. […]. The post Doxepin and CYP2D6 appeared first on Med Ed 101.
Pharma Times
APRIL 9, 2021
A subcutaneous formulation will now be available to treat relapsing-remitting multiple sclerosis
pharmaphorum
APRIL 6, 2021
UK digital health company Oxehealth has claimed FDA approval for software that can be used to remotely measure vital signs like heart and breathing rates from a camera feed. . Oxehealth Vital Signs – which has been approved as a class IIa medical device in Europe since 2018 – operates as part of the company’s Oxevision platform, which consists of an optical sensor installed in a patient’s room and provides continuous remote monitoring.
Outsourcing Pharma
APRIL 8, 2021
An expert from FourKites shares impacts of the February storm that hit Texas and other parts of North America, and lessons can be learned from the event.
Pharma Marketing Network
APRIL 7, 2021
Native advertising may mean something different to you depending on what part of the industry you’re in whether it be in advertising or publishing. . Tune in and listen to the Pharma Marketing Network and fellow thought leaders from, ROI Marketplace, MedThink, and Sharecare.com, discuss their learnings and insights on native advertising from each of their respective vantage points – pharma-marketer, publisher, and agency. .
Pharma Times
APRIL 7, 2021
The NIHR-funded trial will assess whether removing small fibroids and endometrial polyps improves fertility and live births
pharmaphorum
APRIL 7, 2021
In its second licensing deal in the radio-oncology area in consecutive weeks, Novartis has agreed a $1.3 billion-plus alliance with UK biotech Artios Pharma to develop precision medicines for cancer. The collaboration will focus on combining Artios’ DNA damage response (DDR) drug candidates with Novartis’ radioligand therapies, which consist of tumour-targeting molecules carrying radioactive isotopes that can deliver a cell-killing dose of radiation to malignant cells.
Outsourcing Pharma
APRIL 5, 2021
The free Patient-Centric Trial Development Toolkit is aimed toward helping sites and sponsors identify and minimize risks in rare-disease clinical studies.
Expert insights. Personalized for you.
132 
Let's personalize your content